According to the SEC Form 4 filings, Sachdev Amit, being in a position of
No biography is available at this moment.
Buys | $0 | 0 | 0 |
Sells | $28,377,385 | 2 | 100 |
| 2026-02-25 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP Chief Patient & Ext Af Off | 1,846 0.0007% | $486.35 | $897,802 | -0.6% | |
| 2026-02-19 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP Chief Patient & Ext Af Off | 58,613 0.023% | $468.83 | $27.48M | +2.33% | |
| 2024-05-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP Chief Patient & Ext Af Off | 32 <0.0001% | $430.93 | $13,790 | +8.47% | |
| 2024-02-26 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP Chief Patient & Ext Af Off | 3,004 0.0011% | $425.70 | $1.28M | +7.29% | |
| 2024-02-21 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP Chief Patient & Ext Af Off | 3,191 0.0012% | $421.77 | $1.35M | +10.7% | |
| 2024-02-20 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP Chief Patient & Ext Af Off | 4,254 0.0016% | $420.79 | $1.79M | +10.34% | |
| 2024-02-12 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP Chief Patient & Ext Af Off | 3,222 0.0013% | $420.24 | $1.35M | +10.8% | |
| 2023-11-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP Chief Patient & Ext Af Off | 35 <0.0001% | $369.92 | $12,947 | +26.67% | |
| 2023-08-10 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | 10,031 0.0039% | $350.00 | $3.51M | +18.18% | |
| 2021-11-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | 51 <0.0001% | $187.19 | $9,547 | +44.25% | |
| 2021-05-17 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | 45 <0.0001% | $216.35 | $9,736 | -4.41% | |
| 2021-04-27 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | 3,884 0.0015% | $216.06 | $839,193 | -4.05% | |
| 2021-02-25 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | 3,586 0.0014% | $213.42 | $765,307 | -2.9% | |
| 2021-02-18 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | 9,264 0.0036% | $211.83 | $1.96M | -1.39% | |
| 2021-02-11 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | 4,460 0.0017% | $210.55 | $939,068 | -1.76% | |
| 2020-11-16 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | 42 <0.0001% | $223.53 | $9,388 | -6.17% | |
| 2020-08-03 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | 1,941 0.0007% | $278.28 | $540,137 | -22.49% | |
| 2020-05-15 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | 58 <0.0001% | $284.41 | $16,496 | -19.72% | |
| 2020-05-11 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | 10,665 0.0041% | $282.61 | $3.01M | -18.47% | |
| 2020-05-06 | Sale | Vertex Pharmaceuticals Incorporated VRTX | EVP, Chief Patient Officer | 669 0.0003% | $275.28 | $184,162 | -13.36% |